| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 97 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 97 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 97 |
| 3 | DOXORUBICIN | 77 |
| 4 | METHOTREXATE SODIUM | 74 |
| 5 | METHOTREXATE | 67 |
| 6 | ETOPOSIDE | 54 |
| 7 | RITUXIMAB | 49 |
| 8 | CYTARABINE | 41 |
| 9 | IFOSFAMIDE | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXRAZOXANE FOR INJECTION | 6 | 0.0064 |
| 1 | DAUNORUBICIN HYDROCHLORIDE | 8 | 0.0049 |
| 2 | GRANULOCYTE COLONY STIMULATING FACTOR | 7 | 0.0032 |
| 3 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 2 | 0.0020 |
| 4 | DASATINIB | 17 | 0.0018 |
| 5 | IFOSFAMIDE FOR INJECTION | 36 | 0.0017 |
| 6 | RYDAPT | 3 | 0.0015 |
| 7 | GEMTUZUMAB OZOGAMICIN | 5 | 0.0014 |
| 8 | BELANTAMAB MAFODOTIN | 4 | 0.0013 |
| 9 | VINCRISTINE SULFATE | 30 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 113 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 75 |
| 2 | Corticosteroid [EPC] | 70 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 69 |
| 4 | Platinum-based Drug [EPC] | 68 |
| 5 | Topoisomerase Inhibitor [EPC] | 54 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 49 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 41 |
| 8 | Kinase Inhibitor [EPC] | 25 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | CD33-directed Immunoconjugate [EPC] | 5 | 0.0014 |
| 3 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 4 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 5 | Topoisomerase Inhibitor [EPC] | 54 | 0.0007 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 12 | 0.0006 |
| 7 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 8 | Alkylating Drug [EPC] | 113 | 0.0005 |
| 9 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |